Cumberland Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cumberland Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,180	Closed	-$853K	–	62
2015 Q3	$853K	Buy	18,180 +5,100	+39%	+$307K	0.53%	30
2015 Q2	$816K	Buy	13,080 +2,080	+19%	+$130K	0.43%	33
2015 Q1	$679K	Buy	11,000 +4,380	+66%	+$260K	0.35%	35
2014 Q4	$357K	Sell	6,620 -75,080	-92%	-$4.1M	0.21%	36
2014 Q3	$4.33M	Buy	+81,700	New	+$4.15M	2.86%	11

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

Cumberland Advisors's XPH Position: Q4 2015 in Review

Cumberland Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2015, closing a stake of 18,180 shares — an estimated $853K sold.

Cumberland Advisors first reported a position in XPH in Q3 2014 and held it in 5 quarters. The position peaked at $4.33M in Q3 2014. 76 funds tracked by Wall St. Rank hold XPH as of Q4 2015.

Cumberland Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Cumberland Advisors sold 18,180 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2015, an estimated $853K.
Cumberland Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2014 and held it in 5 quarters.
Cumberland Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4.33M in Q3 2014.
76 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2015.

Based on Cumberland Advisors's 13F filing for Q4 2015, filed 20 Jan 2016.